Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

181

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Pancreatic CancerBenign Pancreatic Disease
Trial Locations (1)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Pittsburgh

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER